Correlation Between Inhibrx and Alterity Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Alterity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Alterity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Alterity Therapeutics, you can compare the effects of market volatilities on Inhibrx and Alterity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Alterity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Alterity Therapeutics.

Diversification Opportunities for Inhibrx and Alterity Therapeutics

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Inhibrx and Alterity is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Alterity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterity Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Alterity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterity Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Alterity Therapeutics go up and down completely randomly.

Pair Corralation between Inhibrx and Alterity Therapeutics

Given the investment horizon of 90 days Inhibrx is expected to generate 1.22 times more return on investment than Alterity Therapeutics. However, Inhibrx is 1.22 times more volatile than Alterity Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Alterity Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  1,603  in Inhibrx on September 1, 2024 and sell it today you would lose (77.00) from holding Inhibrx or give up 4.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Inhibrx  vs.  Alterity Therapeutics

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Alterity Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alterity Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Inhibrx and Alterity Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and Alterity Therapeutics

The main advantage of trading using opposite Inhibrx and Alterity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Alterity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterity Therapeutics will offset losses from the drop in Alterity Therapeutics' long position.
The idea behind Inhibrx and Alterity Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings